Theravance Biopharma (TBPH) Receivables - Net (2013 - 2019)
Theravance Biopharma (TBPH) recorded Receivables - Net of $87,000 in Q3 2019, down 97.1% from $3.02 million a year earlier and down 21.6% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Receivables - Net (2013 - 2019) Analysis & Trends
At the end of FY2018, Theravance Biopharma reported Receivables - Net of $620,000, down 72.5% from FY2017.
- Annual Receivables - Net has a five-year compound annual growth rate of 25.5% (FY2013 to FY2018).
- Across earlier years, Receivables - Net came in at $2.25 million in FY2017 (+248.8%), $646,000 in FY2016 (-66.4%), $1.92 million in FY2015 (+565.1%) and $289,000 in FY2014 (+45.2%).
- The Q3 2019 figure is the lowest quarterly Receivables - Net since Q1 2014.
- On a year-over-year basis, Receivables - Net has declined for four consecutive quarters, with growth averaging 24.4% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 794.4% in Q2 2015, against a decline of 97.1% in Q3 2019 at the low end.
- Per Business Quant, the preceding three quarters came in at $111,000 (Q2 2019), $113,000 (Q1 2019) and $620,000 (Q4 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 87,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Dec 31, 2018 | 620,000.00 |
| Sep 30, 2018 | 3.02 Mn |
| Jun 30, 2018 | 3.43 Mn |
| Mar 31, 2018 | 1.97 Mn |
| Dec 31, 2017 | 2.25 Mn |
| Sep 30, 2017 | 1.58 Mn |
| Jun 30, 2017 | 1.35 Mn |
| Mar 31, 2017 | 1.23 Mn |
| Dec 31, 2016 | 646,000.00 |
| Sep 30, 2016 | 873,000.00 |
| Jun 30, 2016 | 1.86 Mn |
| Mar 31, 2016 | 1.53 Mn |
| Dec 31, 2015 | 1.92 Mn |
| Sep 30, 2015 | 783,000.00 |
| Jun 30, 2015 | 805,000.00 |
| Mar 31, 2015 | 565,000.00 |
| Dec 31, 2014 | 289,000.00 |
API Access
Theravance Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();